The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE2
Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS)
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic Osteosarcoma
- Status
- UNKNOWN
- Phase
- PHASE2
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1